正反方对话:可手术切除ⅠB~ⅢA期EGFR突变阳性NSCLC术后辅助治疗模式探索

    Debate of Exploration of Adjuvant Therapy Mode for Postoperative ⅠB~ⅢA EGFR Mutated NSCLC

    /

    返回文章
    返回